NCT01843634View on ClinicalTrials.gov

Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

ODSH

Trial Locations (1)

84112

Huntsman Cancer Institute, Salt Lake City

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY